PERSPECTA

News from every angle

Back to headlines

FDA Grants Clearance for Roche and Eli Lilly Alzheimer’s Blood Tests

Regulatory approval marks a significant milestone in early dementia detection, enabling widespread clinical use of blood-based biomarkers for Alzheimer’s disease diagnosis.

PostShare

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.